Articles & Blogs Pharma & Life Sciences
Thursday, 16 February 2023
The UK pharma pricing scheme - the Voluntary Scheme for Branded Medicines Pricing and Access (known as VPAS) is in crisis, and it must change in the new pricing deal from 2024 onwards in order for the UK to be an attractive place for life sciences.